Literature DB >> 12777687

Functional peptide sequences derived from extracellular matrix glycoproteins and their receptors: strategies to improve neuronal regeneration.

Sally Meiners1, Mary Lynn T Mercado.   

Abstract

Peptides derived from extracellular matrix proteins have the potential to function as potent therapeutic reagents to increase neuronal regeneration following central nervous system (CNS) injury, yet their efficacy as pharmaceutical reagents is dependent upon the expression of cognate receptors in the target tissue. This type of codependency is clearly observed in successful models of axonal regeneration in the peripheral nervous system, but not in the normally nonregenerating adult CNS. Successful regeneration is most closely correlated with the induction of integrins on the surface of peripheral neurons. This suggests that in order to achieve optimal neurite regrowth in the injured adult CNS, therapeutic strategies must include approaches that increase the number of integrins and other key receptors in damaged central neurons, as well as provide the appropriate growth-promoting peptides in a "regeneration cocktail." In this review, we describe the ability of peptides derived from tenascin- C, fibronectin, and laminin-1 to influence neuronal growth. In addition, we also discuss the implications of peptide/receptor interactions for strategies to improve neuronal regeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777687     DOI: 10.1385/MN:27:2:177

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  103 in total

1.  Identification of a 110-kDa nonintegrin cell surface laminin-binding protein which recognizes an A chain neurite-promoting peptide.

Authors:  H K Kleinman; B S Weeks; F B Cannon; T M Sweeney; G C Sephel; B Clement; M Zain; M O Olson; M Jucker; B A Burrous
Journal:  Arch Biochem Biophys       Date:  1991-11-01       Impact factor: 4.013

2.  Directional neurite outgrowth and axonal differentiation of embryonic hippocampal neurons are promoted by a neurite outgrowth domain of the B2-chain of laminin.

Authors:  M Matsuzawa; F F Weight; R S Potember; P Liesi
Journal:  Int J Dev Neurosci       Date:  1996-06       Impact factor: 2.457

3.  Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function.

Authors:  M Obara; M S Kang; K M Yamada
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

4.  Integrin alpha 8 beta 1 promotes attachment, cell spreading, and neurite outgrowth on fibronectin.

Authors:  U Müller; B Bossy; K Venstrom; L F Reichardt
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

5.  Antibodies directed against the beta 1-integrin subunit and peptides containing the IKVAV sequence of laminin perturb neurite outgrowth of peripheral neurons on immature spinal cord substrata.

Authors:  E Agius; Y Sagot; A M Duprat; P Cochard
Journal:  Neuroscience       Date:  1996-04       Impact factor: 3.590

6.  A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1).

Authors:  B E Vogel; G Tarone; F G Giancotti; J Gailit; E Ruoslahti
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

7.  beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin.

Authors:  M C Kibbey; M Jucker; B S Weeks; R L Neve; W E Van Nostrand; H K Kleinman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Nerve growth factor, laminin, and fibronectin promote neurite growth in human fetal sensory ganglia cultures.

Authors:  A Baron-Van Evercooren; H K Kleinman; S Ohno; P Marangos; J P Schwartz; M E Dubois-Dalcq
Journal:  J Neurosci Res       Date:  1982       Impact factor: 4.164

9.  Long and short splice variants of human tenascin differentially regulate neurite outgrowth.

Authors:  S Meiners; H M Geller
Journal:  Mol Cell Neurosci       Date:  1997       Impact factor: 4.314

10.  The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine.

Authors:  A Komoriya; L J Green; M Mervic; S S Yamada; K M Yamada; M J Humphries
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

View more
  7 in total

1.  Effects of neurotoxic and neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo.

Authors:  Y Albert Pan; Thomas Misgeld; Jeff W Lichtman; Joshua R Sanes
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

2.  The role of defensin NP-1 in restoring the functions of an injured nerve trunk.

Authors:  A D Nozdrachev; L I Kolosova; A B Moiseeva; O V Ryabchikova
Journal:  Neurosci Behav Physiol       Date:  2006-03

Review 3.  Biomaterial design strategies for the treatment of spinal cord injuries.

Authors:  Karin S Straley; Cheryl Wong Po Foo; Sarah C Heilshorn
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

Review 4.  Integrins as receptor targets for neurological disorders.

Authors:  Xin Wu; Doodipala Samba Reddy
Journal:  Pharmacol Ther       Date:  2011-12-30       Impact factor: 12.310

5.  Design and adsorption of modular engineered proteins to prepare customized, neuron-compatible coatings.

Authors:  Karin S Straley; Sarah C Heilshorn
Journal:  Front Neuroeng       Date:  2009-06-18

6.  Cortical deficiency of laminin gamma1 impairs the AKT/GSK-3beta signaling pathway and leads to defects in neurite outgrowth and neuronal migration.

Authors:  Zu-Lin Chen; Véronique Haegeli; Huaxu Yu; Sidney Strickland
Journal:  Dev Biol       Date:  2008-12-16       Impact factor: 3.582

7.  Morphology, cytoskeletal organization, and myosin dynamics of mouse embryonic fibroblasts cultured on nanofibrillar surfaces.

Authors:  Ijaz Ahmed; Abdul S Ponery; Alam Nur-E-Kamal; Jabeen Kamal; Adam S Meshel; Michael P Sheetz; Melvin Schindler; Sally Meiners
Journal:  Mol Cell Biochem       Date:  2007-02-09       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.